Works matching DE "TOPOTECAN"

Results: 294

Early patterns of verbal memory impairment in children treated for medulloblastoma.

Published in:

2006

By:

Nagel, Bonnie J.;
Delis, Dean C.;
Palmer, Shawna L.;
Reeves, Cara;
Gajjar, Amar;
Mulhern, Raymond K.

Publication type:

Journal Article

Do's and Don'ts" for intraarterial chemotherapy for retinoblastoma- What ophthalmologist and interventional radiologist need to know?

Published in:

Indian Journal of Ophthalmology, 2025, v. 73, n. 6, p. 916, doi. 10.4103/IJO.IJO_2912_24

By:

Bhatter, Pallav;
Parthasarathy, Rajsrinivas;
Gupta, Vipul;
Dusa, Srinivas Rao;
Aggarwal, Ujjwal;
Das, Sima;
Kumar, Pallav

Publication type:

Article

Development of Peptide Conjugated Chlorogenic Acid Nanoassemblies for Targeting Tumorigenic Cells.

Published in:

Soft Materials, 2015, v. 13, n. 3, p. 150, doi. 10.1080/1539445X.2015.1045076

By:

Sortino, Rachel M.;
Romanelli, Steven M.;
Knoll, Grant A.;
Banerjee, Ipsita A.

Publication type:

Article

A prospective clinical trial of lenalidomide with topotecan in women with advanced epithelial ovarian carcinoma.

Published in:

International Journal of Clinical Oncology, 2011, v. 16, n. 6, p. 666, doi. 10.1007/s10147-011-0243-1

By:

Carter, Jori;
Downs, Levi

Publication type:

Article

Second Line Treatment Choice in Extensive Small Lung Cancer.

Published in:

Eurasian Journal of Medical Investigation, 2022, v. 6, n. 4, p. 456, doi. 10.14744/ejmi.2022.72208

By:

Ay, Seval;
Ozyukseler, Deniz Tataroglu;
Dulgar, Ozgecan;
Atci, Muhammed Mustafa;
Arikan, Rukiye;
Akbiyik, Ayten Guner;
Gumus, Mahmut

Publication type:

Article

Pharmacologic topoisomerase-I inhibition causes DNA damage and mortality in activated CD4<sup>+</sup> T cells.

Published in:

Genetics & Applications, 2018, v. 2, n. 2, p. 51, doi. 10.31383/ga.vol2iss2pp51-56

By:

Stanic, Mia;
Shytaj, Iart Luca;
Lusic, Marina

Publication type:

Article

An economic analysis of cisplatin alone versus cisplatin doublets in the treatment of women with advanced or recurrent cervical cancer.

Published in:

European Journal of Gynaecological Oncology, 2016, v. 37, n. 3, p. 353, doi. 10.12892/ejgo2706.2016

By:

McKim, A.;
Walter, A. C.;
Sheely, K. M.;
Manahan, K. J.;
Geisler, J. P.

Publication type:

Article

Disease Control Rate at 8 Weeks Predicts Subsequent Survival in Platinum-Treated Extensive Stage Small-Cell Lung Cancer: Results From the Southwest Oncology Group (SWOG) Database.

Published in:

2016

By:

Lara Jr, Primo N.;
Moon, James;
Redman, Mary W.;
Semrad, Thomas J.;
Kelly, Karen;
Allen, Jeffrey;
Gitlitz, Barbara;
Mack, Philip C.;
Gandara, David R.;
Lara, Primo N Jr

Publication type:

journal article

Cisplatin, Etoposide, and Bevacizumab Regimen Followed by Oral Etoposide and Bevacizumab Maintenance Treatment in Patients With Extensive-Stage Small Cell Lung Cancer: A Single-Institution Experience.

Published in:

2015

By:

Petrioli, Roberto;
Roviello, Giandomenico;
Laera, Letizia;
Luzzi, Luca;
Paladini, Piero;
Ghiribelli, Claudia;
Voltolini, Luca;
Martellucci, Ignazio;
Bianco, Vincenzo;
Francini, Edoardo

Publication type:

journal article

Outcomes of Platinum-Sensitive Small-Cell Lung Cancer Patients Treated With Platinum/Etoposide Rechallenge: A Multi-Institutional Retrospective Analysis.

Published in:

2015

By:

Genestreti, Giovenzio;
Tiseo, Marcello;
Kenmotsu, Hirotsugu;
Kazushige, Wakuda;
Di Battista, Monica;
Cavallo, Giovanna;
Carloni, Federica;
Bongiovanni, Alberto;
Burgio, Marco Angelo;
Casanova, Claudia;
Metro, Giulio;
Scarpi, Emanuela;
Korkmaz, Taner;
Selcuk, Seber;
Roopa, Kurup;
Califano, Raffaele

Publication type:

journal article

Topotecan or other agents as second-line therapy for relapsed small-cell lung cancer: A meta-analysis of randomized studies.

Published in:

Molecular & Clinical Oncology, 2021, v. 15, n. 4, p. N.PAG, doi. 10.3892/mco.2021.2383

By:

Petrelli, Fausto;
Ghidini, Antonio;
Luciani, Andrea

Publication type:

Article

A phase I/II study of CY and topotecan in patients with high-risk malignancies undergoing autologous hematopoietic cell transplantation: the St Jude long-term follow-up.

Published in:

Bone Marrow Transplantation, 2012, v. 47, n. 11, p. 1448, doi. 10.1038/bmt.2012.51

By:

Kasow, K A;
Stewart, C F;
Barfield, R C;
Wright, N L;
Li, C;
Srivastava, D K;
Leung, W;
Horwitz, E M;
Bowman, L C;
Handgretinger, R;
Hale, G A

Publication type:

Article

Phase II trial of high-dose topotecan, melphalan and CY with autologous stem cell support for multiple myeloma.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 4, p. 510, doi. 10.1038/bmt.2010.160

By:

Kazmi, S. M. A.;
Saliba, R. M.;
Donato, M.;
Wang, M.;
Hosing, C.;
Qureshi, S.;
Anderlini, P.;
Popat, U.;
Champlin, R. E.;
Giralt, S. A.;
Qazilbash, M. H.

Publication type:

Article

Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinoma.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 3, p. 490, doi. 10.1038/bmt.2009.181

By:

Litzow, M. R.;
Peethambaram, P. P.;
Safgren, S. L.;
Keeney, G. L.;
Ansell, S. M.;
Dispenzieri, A.;
Elliott, M. A.;
Gastineau, D. A.;
Gertz, M. A.;
Inwards, D. J.;
Lacy, M. Q.;
Micallef, I. N. M.;
Porrata, L. F.;
Lingle, W. L.;
Hartmann, L. C.;
Frost, M. H.;
Barrette, B. A.;
Long, H. J.;
Suman, V. J.;
Reid, J. M.

Publication type:

Article

Small-cell lung cancer growth inhibition: synergism between NMDA receptor blockade and chemotherapy.

Published in:

Clinical Pharmacology, 2019, v. 11, p. 15, doi. 10.2147/CPAA.S183885

By:

North, William G;
Liu, Fuli;
Dragnev, Konstantin H;
Demidenko, Eugene

Publication type:

Article

Novel Strategy Involving High-Dose Chemotherapy with Stem Cell Rescue Followed by Intrathecal Topotecan Maintenance Therapy without Whole-Brain Irradiation for Atypical Teratoid/Rhabdoid Tumors.

Published in:

Pediatric Hematology & Oncology, 2023, v. 40, n. 7, p. 629, doi. 10.1080/08880018.2023.2220734

By:

Yamada, Ai;
Kinoshita, Mariko;
Kamimura, Sachiyo;
Jinnouchi, Takashi;
Azuma, Minako;
Yamashita, Shinji;
Yokogami, Kiyotaka;
Takeshima, Hideo;
Moritake, Hiroshi

Publication type:

Article

Escalating Topotecan in Combination with Treosulfan has Acceptable Toxicity in Advanced Pediatric Sarcomas.

Published in:

Pediatric Hematology & Oncology, 2013, v. 30, n. 4, p. 263, doi. 10.3109/08880018.2013.777948

By:

Bauer, F.;
Filipiak-Pittroff, B.;
Wawer, A.;
von Luettichau, I.;
Burdach, S.

Publication type:

Article

A Modified Protocol with Vincristine, Topotecan, and Cyclophosphamide for Recurrent/Progressive Ewing Sarcoma Family Tumors.

Published in:

Pediatric Hematology & Oncology, 2013, v. 30, n. 3, p. 170, doi. 10.3109/08880018.2013.767868

By:

Kebudi, Rejin;
Cakir, Fatma Betul;
Gorgun, Omer;
Agaoglu, Fulya Yaman;
Darendeliler, Emin

Publication type:

Article

A temperature-sensitive phase-change hydrogel of topotecan achieves a long-term sustained antitumor effect on retinoblastoma cells.

Published in:

OncoTargets & Therapy, 2019, v. 12, p. 6069, doi. 10.2147/OTT.S214024

By:

Huo, Yan;
Wang, Qun;
Liu, Ying;
Wang, Junyi;
Li, Qian;
Li, Zongyuan;
Dong, Yan;
Huang, Yifei;
Wang, Liqiang

Publication type:

Article

Survival analysis in second-line and third-line chemotherapy with irinotecan followed by topotecan or topotecan followed by irinotecan for extensive-stage small-cell lung cancer patients: a single-center retrospective study.

Published in:

OncoTargets & Therapy, 2016, v. 9, p. 1921, doi. 10.2147/ott.s101390

By:

Gokmen Aktas;
Tulay Kus;
Mehmet Emin Kalender;
Alper Sevinc;
Celaletdin Camci;
Seval Kul

Publication type:

Article

Three different mutations in the DNA topoisomerase 1B in Leishmania infantum contribute to resistance to antitumor drug topotecan.

Published in:

Parasites & Vectors, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13071-021-04947-4

By:

Rosa-Teijeiro, Chloé;
Wagner, Victoria;
Corbeil, Audrey;
d'Annessa, Ilda;
Leprohon, Philippe;
do Monte-Neto, Rubens L.;
Fernandez-Prada, Christopher

Publication type:

Article

Ferroptosis Inducers Erastin and RSL3 Enhance Adriamycin and Topotecan Sensitivity in ABCB1/ABCG2-Expressing Tumor Cells.

Published in:

International Journal of Molecular Sciences, 2025, v. 26, n. 2, p. 635, doi. 10.3390/ijms26020635

By:

Perera, Lalith;
Brown, Shalyn M.;
Silver, Brian B.;
Tokar, Erik J.;
Sinha, Birandra K.

Publication type:

Article

Topotecan synergizes with CHEK1 (CHK1) inhibitor to induce apoptosis in ovarian cancer cells.

Published in:

BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1231-z

By:

Kim, Marianne K.;
James, Jana;
Annunziata, Christina M.

Publication type:

Article

Status epilepticus associated with platinum chemotherapy in a patient with cervical cancer: a case report.

Published in:

2015

By:

Holman, Laura L;
Ren, Yulan;
Westin, Shannon N

Publication type:

journal article

Synthetic Lethal Screen Identifies NF-κB as a Target for Combination Therapy with Topotecan for patients with Neuroblastoma.

Published in:: BMC Cancer, 2012, v. 12, n. 1, p. 101, doi. 10.1186/1471-2407-12-101
Publication type:: Article

Systematic Review of topotecan (Hycamtin) inrelapsed small cell lung cancer.

Published in:

BMC Cancer, 2010, v. 10, p. 436, doi. 10.1186/1471-2407-10-436

By:

Riemsma, Rob;
Simons, Jean P.;
Bashir, Zahid;
Gooch, Caroline L.;
Kleijnen, Jos

Publication type:

Article

Pazopanib with Topotecan weekly for patients with platinum-resistant or intermediate-sensitive recurrent ovarian cancer: results of a multicentre, open label phase I/II study (TOPAZ).

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 10, p. 7637, doi. 10.1007/s00432-023-04647-9

By:

Chekerov, Radoslav;
Arndt, Tjadina;
Pietzner, Klaus;
Canzler, Ulrich;
Wimberger, Pauline;
Strauß, Hans-Georg;
Mahner, Sven;
Woelber, Linn;
de Gregorio, Nikolaus;
Stocker, Gertraud;
von Abel, Ekkehard;
Neunhoeffer, Tanja;
Belau, Antje Kristina;
Mustea, Alexander;
Yalinkaya, Isil;
Braicu, Elena Ioana;
Richter, Rolf;
Sehouli, Jalid

Publication type:

Article

The chemotherapeutic agent topotecan differentially modulates the phenotype and function of dendritic cells.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 8, p. 1315, doi. 10.1007/s00262-013-1431-9

By:

Trojandt, Stefanie;
Knies, Diana;
Pektor, Stefanie;
Ritz, Sandra;
Mailänder, Volker;
Grabbe, Stephan;
Reske-Kunz, Angelika;
Bros, Matthias

Publication type:

Article

Optimization of Intra-Arterial Administration of Chemotherapeutic Agents for Glioblastoma in the F98-Fischer Glioma-Bearing Rat Model.

Published in:

Biomolecules (2218-273X), 2025, v. 15, n. 3, p. 421, doi. 10.3390/biom15030421

By:

Latulippe, Juliette;
Roy, Laurent-Olivier;
Gobeil, Fernand;
Fortin, David

Publication type:

Article

Quantification of the interceptor action of caffeine on the in vitro biological effect of the anti-tumour agent topotecan.

Published in:

European Biophysics Journal, 2011, v. 40, n. 8, p. 969, doi. 10.1007/s00249-011-0712-5

By:

Evstigneev, M.;
Mosunov, A.;
Evstigneev, V.;
Parkes, H.;
Davies, D.

Publication type:

Article

Structures of ABCG2 under turnover conditions reveal a key step in the drug transport mechanism.

Published in:

Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-24651-2

By:

Yu, Qin;
Ni, Dongchun;
Kowal, Julia;
Manolaridis, Ioannis;
Jackson, Scott M.;
Stahlberg, Henning;
Locher, Kaspar P.

Publication type:

Article

Simultaneous Analysis of Topotecan and Capsaicin by Micellar Liquid Chromatography.

Published in:

International Journal of Pharmaceutical Investigation, 2023, v. 13, n. 1, p. 94, doi. 10.5530/223097131802

By:

Saraf, Shivani;
Pahade, Priyanka;
Bose, Devashish;
Jain, Sanjay K.

Publication type:

Article

Randomized phase III trial in extended stage small cell lung cancer comparing first line platinum in combination with etoposide or topotecan.

Published in:

2023

By:

Mau-Sørensen, Morten;
Gerner-Rasmussen, Jonas;
Hansen, Olfred;
Holm, Bente;
Nyhus, Christa Haugaard;
McCulloch, Tine;
Nielsen, Henrik Anker;
Wedervang, Kim;
Rytter, Carsten;
Jeppesen, Nina;
Langer, Seppo W.

Publication type:

Letter

Pegylated Liposomal Doxorubicin for Advanced Ovarian Cancer in Women Who are Refractory to Both Platinum- and Paclitaxel-Based Chemotherapy Regimens.

Published in:

Clinical Medicine: Therapeutics, 2009, n. 1, p. 1227, doi. 10.4137/CMT.S2219

By:

Sugiyama, Toru;
Kumagai, Seisuke

Publication type:

Article

Topoisomerase I Inhibitors, Shikonin and Topotecan, Inhibit Growth and Induce Apoptosis of Glioma Cells and Glioma Stem Cells.

Published in:

PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0081815

By:

Zhang, Feng-Lei;
Wang, Ping;
Liu, Yun-Hui;
Liu, Li-bo;
Liu, Xiao-Bai;
Li, Zhen;
Xue, Yi-Xue

Publication type:

Article

Carboplatin +/− Topotecan Ophthalmic Artery Chemosurgery for Intraocular Retinoblastoma.

Published in:

PLoS ONE, 2013, v. 8, n. 8, p. 1, doi. 10.1371/journal.pone.0072441

By:

Francis, Jasmine H.;
Gobin, Y. Pierre;
Dunkel, Ira J.;
Marr, Brian P.;
Brodie, Scott E.;
Jonna, Gowtham;
Abramson, David H.

Publication type:

Article

Development and Validation of an Immunoassay for Quantification of Topoisomerase I in Solid Tumor Tissues.

Published in:

PLoS ONE, 2012, v. 7, n. 12, p. 1, doi. 10.1371/journal.pone.0050494

By:

Pfister, Thomas D.;
Hollingshead, Melinda;
Kinders, Robert J.;
Zhang, Yiping;
Evrard, Yvonne A.;
Ji, Jiuping;
Khin, Sonny A.;
Borgel, Suzanne;
Stotler, Howard;
Carter, John;
Divelbiss, Raymond;
Kummar, Shivaani;
Pommier, Yves;
Parchment, Ralph E.;
Tomaszewski, Joseph E.;
Doroshow, James H.

Publication type:

Article

CK2-Mediated Hyperphosphorylation of Topoisomerase I Targets Serine 506, Enhances Topoisomerase I-DNA Binding, and Increases Cellular Camptothecin Sensitivity.

Published in:

PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0050427

By:

Bandyopadhyay, Keya;
Pingchuan Li;
Gjerset, Ruth A.

Publication type:

Article

EZN-2208 (PEG-SN38) Overcomes ABCG2-Mediated Topotecan Resistance in BRCA1-Deficient Mouse Mammary Tumors.

Published in:

PLoS ONE, 2012, v. 7, n. 9, p. 1, doi. 10.1371/journal.pone.0045248

By:

Zander, Serge A. L.;
Sol, Wendy;
Greenberger, Lee;
Yixian Zhang;
van Tellingen, Olaf;
Jonkers, Jos;
Borst, Piet;
Rottenberg, Sven;
Jian-Ting Zhang

Publication type:

Article

The Inhibition of Autophagy Sensitises Colon Cancer Cells with Wild-Type p53 but Not Mutant p53 to Topotecan Treatment.

Published in:

PLoS ONE, 2012, v. 7, n. 9, p. 1, doi. 10.1371/journal.pone.0045058

By:

Dan-Dan Li;
Ting Sun;
Xiao-Qi Wu;
Shu-Peng Chen;
Rong Deng;
Shan Jiang;
Gong-Kan Feng;
Jing-Xuan Pan;
Xiao-Shi Zhang;
Yi-Xin Zeng;
Xiao-Feng Zhu;
Fimia, Gian Maria

Publication type:

Article

Structure and Function of ABCG2-Rich Extracellular Vesicles Mediating Multidrug Resistance.

Published in:

PLoS ONE, 2011, v. 6, n. 1, p. 1, doi. 10.1371/journal.pone.0016007

By:

Goler-Baron, Vicky;
Assaraf, Yehuda G.

Publication type:

Article

Structural and Dynamical Effects Induced by the Anticancer Drug Topotecan on the Human Topoisomerase I -- DNA Complex.

Published in:

PLoS ONE, 2010, v. 5, n. 6, p. 1, doi. 10.1371/journal.pone.0010934

By:

Mancini, Giordano;
D'Annessa, Ilda;
Coletta, Andrea;
Sanna, Nico;
Chillemi, Giovanni;
Desideri, Alessandro

Publication type:

Article

Enhanced synergistic antitumor efficacy with topotecan (camptothecin derivative) and curcumin analogs coadministration in novel proniosomal formulations.

Published in:

Pharmacognosy Magazine, 2022, v. 18, n. 77, p. 233, doi. 10.4103/pm.pm_588_21

By:

Asif, Afzal;
Shiroorkar, Predeepkumar;
Singh, Purna;
Shinu, Pottathil;
Sreeharsha, Nagaraja;
Anwer, Md

Publication type:

Article

Topotecan and vincristine combination is effective against advanced bilateral intraocular retinoblastoma and has manageable toxicity.

Published in:

Cancer (0008543X), 2012, v. 118, n. 22, p. 5663, doi. 10.1002/cncr.27563

By:

Qaddoumi, Ibrahim;
Billups, Catherine A.;
Tagen, Michael;
Stewart, Clinton F.;
Wu, Jianrong;
Helton, Kathleen;
McCarville, M. Beth;
Merchant, Thomas E.;
Brennan, Rachel;
Free, Tammy M.;
Given, Vicki;
Haik, Barrett G.;
Rodriguez-Galindo, Carlos;
Wilson, Matthew W.

Publication type:

Article

Combined weekly topotecan and biweekly bevacizumab in women with platinum-resistant ovarian, peritoneal, or fallopian tube cancer.

Published in:

Cancer (0008543X), 2011, v. 117, n. 16, p. 3731, doi. 10.1002/cncr.25967

By:

McGonigle, Kathryn F.;
Muntz, Howard G.;
Vuky, Jacqueline;
Paley, Pamela J.;
Veljovich, Dan S.;
Greer, Benjamin E.;
Goff, Barbara A.;
Gray, Heidi J.;
Malpass, Thomas W.

Publication type:

Article

The selective Trk inhibitor AZ623 inhibits brain-derived neurotrophic factor-mediated neuroblastoma cell proliferation and signaling and is synergistic with topotecan.

Published in:

Cancer (0008543X), 2011, v. 117, n. 6, p. 1321, doi. 10.1002/cncr.25674

By:

Zage, Peter E.;
Graham, Timothy C.;
Zeng, Lizhi;
Fang, Wendy;
Pien, Christine;
Thress, Ken;
Omer, Charles;
Brown, Jeffrey L.;
Zweidler-McKay, Patrick A.

Publication type:

Article

Subconjunctival Carboplatin and Systemic Topotecan Treatment in Preclinical Models of Retinoblastoma.

Published in:

Cancer (0008543X), 2011, v. 117, n. 2, p. 421, doi. 10.1002/cncr.25574

By:

Nemeth, Katie M.;
Federico, Sara;
Carcaboso, Angel M.;
Ying Shen;
Schaiquevich, Paula;
Jiakun Zhang;
Egorin, Merrill;
Stewart, Clinton;
Dyer, Michael A.

Publication type:

Article

Combination of Cladribine Plus Topotecan for Recurrent or Refractory Pediatric Acute Myeloid Leukemia.

Published in:

Cancer (0008543X), 2010, v. 116, n. 1, p. 98, doi. 10.1002/cncr.24712

By:

Inaba, Hiroto;
Stewart, Clinton F.;
Crews, Kristine P.;
Shengping Yang;
Pounds, Stanley;
Ching-Hon Pui;
Rubnftz, Jeffrey E.;
Razzouk, Bassem I.;
Ribeiro, Raul C.

Publication type:

Article

Summaries of safety labeling changes approved by FDA--Boxed warnings highlights, July--September 2018.

Published in:: 2018
Publication type:: Abstract

Summaries of safety labeling changes approved by FDA--Boxed warnings highlights, July--September 2018.

Published in:: 2018
Publication type:: Abstract